The COL6A3 gene DYT27 genetic test is a specialized diagnostic tool designed to detect mutations in the COL6A3 gene, which have been associated with DYT27 dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, resulting in twisting and repetitive movements or abnormal postures. The COL6A3 gene plays a crucial role in the production of collagen, a protein that is essential for the structure and function of connective tissues throughout the body.
This genetic test is critical for individuals who exhibit symptoms of dystonia, as identifying the specific genetic mutation can aid in the diagnosis, management, and treatment of the condition. It can also provide valuable information for family planning and genetic counseling for families affected by DYT27 dystonia.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the COL6A3 gene DYT27 genetic test is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists and technicians, the test involves analyzing the patient's DNA sample (usually collected via a blood sample) to search for mutations in the COL6A3 gene. Results from this test can help guide healthcare providers in developing a personalized treatment plan for patients affected by DYT27 dystonia, enhancing their quality of life.
The PRX Gene Dejerine-Sottas Disease Genetic Test is a specialized diagnostic tool used to identify mutations in the PRX gene, which are associated with Dejerine-Sottas Disease (DSD), also known as Hereditary Motor and Sensory Neuropathy Type III. DSD is a rare, inherited neurological disorder characterized by progressive muscle weakness and sensory loss, primarily affecting the peripheral nervous system. Early detection through genetic testing can be crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.
Conducted at DNA Labs UAE, this genetic test offers a comprehensive analysis of the PRX gene to detect mutations that may lead to the development of Dejerine-Sottas Disease. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies to identify any genetic abnormalities.
The cost of the PRX Gene Dejerine-Sottas Disease Genetic Test is 4400 AED. While the price may seem high, the value of the information gained can be significant for patients and their families, providing insights into the genetic basis of the condition, enabling early intervention, and facilitating informed decisions about care and management. It is advisable for individuals considering this test to consult with a healthcare professional or a genetic counselor to understand the implications of the results and the next steps in the context of their personal and family health history.
The ITM2B Gene Dementia Familial Danish Type Genetic Test is a specialized diagnostic procedure designed to detect mutations in the ITM2B gene, which are associated with Familial Danish Dementia (FDD). This rare form of dementia is inherited in an autosomal dominant pattern and is characterized by symptoms such as progressive cognitive decline, hearing loss, cataracts, and cerebellar ataxia. The genetic test plays a crucial role in confirming the diagnosis, enabling early intervention and management strategies for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab. The laboratory then analyzes the sample to identify any mutations in the ITM2B gene that are indicative of Familial Danish Dementia. The process is highly accurate and provides vital information for the genetic counseling of families, helping them understand the risk of inheritance and consider future reproductive choices.
The cost of the ITM2B Gene Dementia Familial Danish Type Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected families in terms of planning, management, and support cannot be overstated. Early diagnosis through this test can significantly impact the quality of life of individuals with Familial Danish Dementia and their caregivers by allowing for timely interventions and support systems to be put in place.
The TARDBP Gene Dementia Frontotemporal Genetic Test is a specialized diagnostic tool designed to identify mutations in the TARDBP gene, which have been linked to frontotemporal dementia (FTD). This condition is a type of dementia characterized by progressive damage to the frontal and/or temporal lobes of the brain, affecting behavior, language, and emotional control. The test is particularly crucial for individuals with a family history of FTD, as it can provide valuable insights into their genetic predisposition to developing the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to detect specific genetic alterations in the TARDBP gene that are associated with the development of frontotemporal dementia. The process is non-invasive, usually requiring only a blood sample or cheek swab from the patient.
The cost of the TARDBP Gene Dementia Frontotemporal Genetic Test is 4400 AED. While the price may seem significant, the test offers crucial information that can aid in early diagnosis, allowing for better management of the condition through tailored treatment plans and lifestyle adjustments. Early diagnosis can also help families prepare for the future and make informed decisions regarding care and support for their loved ones.
In summary, the TARDBP Gene Dementia Frontotemporal Genetic Test at DNA Labs UAE is a valuable diagnostic tool for individuals at risk of developing frontotemporal dementia, providing them with early detection and the opportunity to manage the condition proactively.
The SNCA Gene Dementia Lewy Body Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SNCA gene, which are associated with an increased risk of developing Lewy body dementia (LBD). Lewy body dementia is a progressive brain disorder characterized by the abnormal accumulation of alpha-synuclein protein in the brain, leading to cognitive decline, movement disorders, and psychiatric symptoms. By analyzing the SNCA gene, this test helps in confirming the diagnosis, understanding the risk, and aiding in the management of the condition for patients and their families. The test is priced at 4400 AED, reflecting the comprehensive analysis and the specialized technology utilized in identifying the genetic variations linked to this form of dementia. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test represents a crucial step forward in the personalized treatment and understanding of Lewy body dementia.
The OCRL Gene Dent Disease Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the OCRL gene, which are associated with Dent Disease Type 2. This rare genetic disorder is characterized by kidney problems, including excessive excretion of proteins and other substances in the urine, which can lead to kidney failure and other complications. The test is crucial for early detection and management of the condition, providing essential information for healthcare providers to develop an appropriate treatment plan. Priced at 4400 AED, the test represents a significant step towards personalized medicine, enabling targeted interventions that can significantly improve the quality of life for individuals with Dent Disease Type 2.
The ATN1 Gene Dentatorubral-Pallidoluysian Atrophy (DRPLA) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the ATN1 gene, which are responsible for causing Dentatorubral-Pallidoluysian Atrophy. DRPLA is a rare, autosomal dominant neurodegenerative disorder characterized by a wide range of neurological symptoms, including ataxia, choreoathetosis, seizures, and cognitive decline, which tend to worsen over time. The onset of symptoms can vary greatly, appearing in childhood or adulthood, making early and accurate diagnosis crucial for managing the condition.
This genetic test involves analyzing the patient's DNA to identify mutations in the ATN1 gene that indicate the presence of DRPLA. By pinpointing these genetic abnormalities, healthcare providers can confirm a diagnosis of DRPLA, allowing for early intervention, appropriate management strategies, and genetic counseling for affected families. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the specific genetic alterations associated with this condition.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate, reliable results, the ATN1 Gene DRPLA Genetic Test represents a crucial resource for individuals and families at risk of this challenging disorder, offering hope for better understanding and management of their condition.
The SLC1A4 gene is essential in the development and functioning of the central nervous system. Mutations in this gene have been linked to developmental delays and microcephaly, a condition characterized by a smaller head size indicative of abnormal brain development. These conditions can lead to various neurological issues and developmental challenges, significantly affecting an individual's quality of life. Recognizing the importance of early diagnosis and intervention, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the SLC1A4 gene.
This test is a crucial tool for families and healthcare providers, offering insights that can lead to better-informed decisions regarding care and management. By understanding the genetic underpinnings of these conditions, tailored therapies and support systems can be implemented, potentially improving developmental outcomes.
The cost of the SLC1A4 related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any abnormalities associated with the gene, providing a critical step towards personalized medical care for affected individuals. With the results, healthcare professionals can devise a more targeted approach in managing and supporting the developmental needs of those with mutations in the SLC1A4 gene, emphasizing the test's value in enhancing patient care.
The GNAQ gene is implicated in a variety of biological processes within the human body, including cell signaling pathways that are crucial for normal development and function. Mutations in the GNAQ gene can lead to developmental delays and a range of other medical conditions. Recognizing the importance of early detection and intervention, DNA Labs UAE offers a specialized genetic test specifically designed to identify mutations in the GNAQ gene that may be responsible for developmental delays and related disorders.
This test is a critical tool for healthcare providers and families concerned about genetic conditions affecting development. By analyzing an individual's DNA, the test can pinpoint specific mutations in the GNAQ gene, providing valuable insights into potential health risks and guiding personalized treatment plans.
Priced at 4400 AED, the GNAQ Related Genetic Test at DNA Labs UAE is a comprehensive analysis aimed at those who may be at risk of developmental delays due to genetic factors. The cost of the test reflects the advanced technology and expertise required to accurately identify mutations in the GNAQ gene. Upon completion, the test results can help in making informed decisions about the management and care of affected individuals, ultimately improving their quality of life.
Conducted in a state-of-the-art facility, DNA Labs UAE ensures the confidentiality and accuracy of the testing process, providing support and guidance throughout. This test is a valuable resource for families seeking answers about developmental delays and their potential genetic causes, offering a pathway towards targeted interventions and support.
The KMT2C gene is crucial in human development, playing a significant role in the regulation of gene expression through its involvement in chromatin modification. Mutations in the KMT2C gene can lead to a range of developmental delays and neurodevelopmental disorders, making it a key focus for genetic testing in individuals presenting with such clinical features.
At DNA Labs UAE, a specialized genetic test targeting the KMT2C gene is offered to diagnose conditions related to its mutations. This test is particularly important for families and individuals seeking a deeper understanding of developmental delays and seeking targeted interventions or therapies. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the KMT2C gene that could be responsible for the observed clinical symptoms.
The cost of the KMT2C-related genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, encompassing the advanced genetic sequencing technologies used and the expert analysis required to interpret the results accurately. Given the potential impact of a KMT2C gene mutation on an individual's development, this test represents a crucial step towards personalized medical care, offering insights that can guide therapeutic decisions and support.
It's important for individuals considering this test to consult with a genetic counselor or a healthcare professional who can provide detailed information about the implications of the test results and the next steps in the management or treatment of conditions associated with KMT2C gene mutations.
